Back to search

Article

Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

2024-05-17

Abstract excerpt

Hermansky-Pudlak syndrome (HPS) is a group of rare genetic disorders, with several subtypes leading to fatal adult-onset pulmonary fibrosis (PF) and no effective treatment. Circulating biomarkers detecting early PF have not been identified. We investigated whether endocannabinoids could serve as blood biomarkers of PF in HPS. We measured endocannabinoids in the serum of HPS, IPF, and healthy human subjects and in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
29d21a07-2967-5ba3-b1eb-0a0df5a0a9e4
DOI
10.1101/2024.05.16.24307300
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary FibrosisDOI 10.1101/2024.05.16.24307300
Select a neighboring publication to make it the new centre.